Savina Malancona

发表

Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.

U. Koch, M. Rowley, V. Summa, 2010, Bioorganic & medicinal chemistry.

Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.

F. Lori, E. Réal, S. Harper, 2017, ACS chemical biology.

5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.

E. Réal, S. Harper, M. Botta, 2020, ACS medicinal chemistry letters.

Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs.

S. Harper, S. Altamura, N. Gennari, 2016, ACS medicinal chemistry letters.

Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase

U. Koch, F. Narjes, N. Gennari, 2009, ChemMedChem.

Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase.

U. Koch, F. Narjes, I. Stansfield, 2006, Bioorganic & medicinal chemistry letters.

Diastereoselective synthesis of 4,5-dihydrofurans by iodoenolcyclisation of 2-allyl-1,3-dicarbonyl compounds

P. Bovicelli, Savina Malancona, R. Antonioletti, 2002 .

Improved modular synthesis of thieno[3,2-b]pyrroles and thieno[2,3-b]pyrroles

J. I. Hernando, F. Narjes, J. Ontoria, 2009 .

2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis.

Uwe Koch, Steven Thomas, Frank Narjes, 2006, Journal of medicinal chemistry.

Iodoenolcyclisation of 2-(1,3-disubstituted-1-allyl)-1,3-dicarbonyl compounds: diastereoselective synthesis of tetrasubstituted dihydrofurans

F. Cattaruzza, P. Bovicelli, Savina Malancona, 2003 .

A new route to 2-alkenyl-1,3-dicarbonyl compounds, intermediates in the synthesis of dihydrofurans

P. Bovicelli, Savina Malancona, R. Antonioletti, 2002 .

Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors.

E. H. Rydberg, U. Koch, R. De Francesco, 2009, Journal of medicinal chemistry.

A New Route to 2-Alkenyl-1,3-dicarbonyl Compounds, Intermediates in the Synthesis of Dihydrofurans.

P. Bovicelli, Savina Malancona, R. Antonioletti, 2002 .

Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein.

M. Botta, M. Zazzi, Y. Mély, 2018, ACS medicinal chemistry letters.

Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides.

S. Harper, V. Summa, P. Pace, 2018, ACS medicinal chemistry letters.

Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2.

J. I. Hernando, S. Altamura, M. Rowley, 2011, Bioorganic & medicinal chemistry letters.

Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease.

U. Koch, F. Narjes, V. Matassa, 2004, Bioorganic & medicinal chemistry letters.

Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration.

S. Harper, D. Elbaum, Giulio Auciello, 2020, Journal of medicinal chemistry.

Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.

S. Harper, N. Gennari, V. Summa, 2018, Bioorganic & medicinal chemistry letters.

SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.

F. Narjes, I. Stansfield, V. Matassa, 2004, Bioorganic & medicinal chemistry letters.

Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs.

S. Harper, S. Altamura, N. Gennari, 2016, ACS medicinal chemistry letters.